IDXX Q2 2019 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q2 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$620M+6.8% YoY

Gross Profit

$358M57.7% margin

Operating Income

$164M26.5% margin

Net Income

$126M20.3% margin

EPS (Diluted)

$1.43

QoQ Revenue Growth

+7.6%

Cash Flow

Operating Cash Flow

$137M

Free Cash Flow

$103M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$1.6B

Stockholders' Equity

$171M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$620M	$581M	+6.8%
Gross Profit	$358M	$332M	+7.6%
Operating Income	$164M	$146M	+12.8%
Net Income	$126M	$109M	+15.7%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$1.5B96%

Reagent Rental Programs

$34M2%

Extended Warranties And Post Contract Support

$26M2%

Instrument Rebate Programs

$5M0%

Geographic Segments

UNITED STATES

$389M79%

Asia Pacific

$64M13%

CANADA

$28M6%

Latin America

$15M3%